ABUS Arbutus Biopharma Corp

USD 2.98 0.00 0
Icon

Arbutus Biopharma Corp (ABUS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.98

0.00 (0.00)%

USD 0.56B

0.75M

USD 4.25(+42.62%)

USD 4.75 (+59.40%)

Icon

ABUS

Arbutus Biopharma Corp (USD)
COMMON STOCK | NSD
USD 2.98
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.56B

USD 4.75 (+59.40%)

USD 2.98

Arbutus Biopharma Corp (ABUS) Stock Forecast

Show ratings and price targets of :
USD 4.25
(+42.62%)

Based on the Arbutus Biopharma Corp stock forecast from 3 analysts, the average analyst target price for Arbutus Biopharma Corp is USD 4.25 over the next 12 months. Arbutus Biopharma Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Arbutus Biopharma Corp is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Arbutus Biopharma Corp’s stock price was USD 2.98. Arbutus Biopharma Corp’s stock price has changed by +3.47% over the past week, +9.16% over the past month and +19.20% over the last year.

No recent analyst target price found for Arbutus Biopharma Corp
No recent average analyst rating found for Arbutus Biopharma Corp

Company Overview Arbutus Biopharma Corp

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product can...Read More

https://www.arbutusbio.com

701 Veterans Circle, Warminster, PA, United States, 18974

73

December

USD

USA

Adjusted Closing Price for Arbutus Biopharma Corp (ABUS)

Loading...

Unadjusted Closing Price for Arbutus Biopharma Corp (ABUS)

Loading...

Share Trading Volume for Arbutus Biopharma Corp Shares

Loading...

Compare Performance of Arbutus Biopharma Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABUS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Arbutus Biopharma Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD109.10B 27.47 20.00

ETFs Containing ABUS

Symbol Name ABUS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Arbutus Biopharma Corp (ABUS) Stock

Based on ratings from 3 analysts Arbutus Biopharma Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on ABUS's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ABUS is USD 4.25 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 4.

Unfortunately we do not have enough data on ABUS's stock to indicate if its overvalued.

The last closing price of ABUS's stock was USD 2.98.

The most recent market capitalization for ABUS is USD 0.56B.

Based on targets from 3 analysts, the average taret price for ABUS is projected at USD 4.25 over the next 12 months. This means that ABUS's stock price may go up by +42.62% over the next 12 months.

We can't find any ETFs which contains Arbutus Biopharma Corp's stock.

As per our most recent records Arbutus Biopharma Corp has 73 Employees.

Arbutus Biopharma Corp's registered address is 701 Veterans Circle, Warminster, PA, United States, 18974. You can get more information about it from Arbutus Biopharma Corp's website at https://www.arbutusbio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...